SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing a dramatic surge, fueled by impending Chinese export restrictions on silver and strong community sentiment that years of market suppression are finally breaking. Investors are actively debating if this is a true price discovery for silver as a critical industrial and monetary metal or an unsustainable bubble, with many anticipating significant price appreciation as de-dollarization concerns grow.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending because of its incredibly active and conviction-driven community, which passionately champions the "OG meme" narrative of Rage Comics. This dedicated base is continuously building out the ecosystem with projects like RageMaker and RageGames, aiming to onboard new users into the crypto space. The community views RAGE as significantly undervalued, expressing strong belief in its potential for substantial long-term growth, with many discussing a target of "billions" or "51B."

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is drawing significant attention for its Gemini-II APU, which proponents laud for its ultra-low power and compute-in-memory architecture, seeing it as a game-changer for edge AI in defense and space applications. While many anticipate further catalysts from ongoing military partnerships and upcoming LLM benchmarks, the community also shows caution regarding its long-term commercial adoption and recent insider transactions.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending amidst a historic surge in silver prices, driven by an acute global supply deficit and strong industrial demand. The community expresses significant frustration over the stock's current lagging performance, attributing it to market manipulation, but remains highly optimistic for an eventual explosive 'catch-up' rally. Long-term bullish sentiment is fueled by expectations of sustained physical demand and potential catalysts like the Jerritt Canyon update.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

Alpha Capital Acquisition Co (ASPC) is trending due to an extraordinary surge in trading volume and price, sparking intense community discussion about a potential short squeeze. Fueling the conversation are mentions of its low float and extremely high borrow rates, leading many to speculate on significant further upward movement, while others express caution regarding its volatile nature.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

YEE Crypto is trending with strong upward momentum, fueled by an enthusiastic community deeply invested in a "9-year prophecy" narrative. Many believe it represents the resurgence of "OG memecoin culture" on Ethereum, aligning with a broader "ETH season" and attracting significant community conviction through consistent dip buying.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is actively trending as the community anticipates a monumental silver squeeze, driven by a global supply shortage and escalating industrial demand from sectors like EVs and AI. Investors are highlighting a belief that decades of price suppression are finally breaking, leading many to advocate for physically-backed options like PSLV over traditional paper silver ETFs. This situation is further amplified by macro concerns about currency debasement and inflation, positioning silver for a significant revaluation.

Hecla Mining Co. engages in the provision of precious and base metals. It operates through the following segments: Greens Creek, Lucky Friday, Keno Hill, Casa Berardi, and Other. The company was founded by Amasa B. Campbell, Patsy Clark, and John Finch on October 14, 1891 and is headquartered in Coeur d'Alene, ID.

Hecla Mining Co.

Hecla Mining (HL) is trending amidst a booming silver market, fueled by severe global supply shortages and surging industrial demand driving spot prices dramatically higher. Despite community concerns over perceived market manipulation, many anticipate HL and other miners to eventually "explode higher" and significantly outperform silver, especially given Hecla's upcoming production increases and exploration catalysts.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power (SMR) is experiencing extreme volatility and divided investor sentiment following a significant price correction, driven by concerns over ongoing institutional share sales and an upcoming vote on potential share dilution. However, a segment of the community views the current dip as a buying opportunity, emphasizing NuScale's NRC-certified SMR technology as crucial for addressing the escalating energy demands of AI data centers and future global power needs.

Telcoin is a multi-national fintech company  integrating blockchain technology, telecommunications, and digital banking to revolutionize global finance. It aims to provide borderless, instant, and affordable financial services to mobile phone users worldwide. Telcoin offers the Telcoin Wallet, a multi-signature DeFi wallet supporting more than 100 digital assets and remittances to eWallets and bank accounts globally. Telcoin is regulated as a Virtual Asset Service Provider in the EU (Lithuania) and Argentina, a Major Payment Institution in Singapore, and a Money Services Business in the US, Canada, and Australia.   Telcoin is designed to complement telecom, mobile money, and e-wallet partners globally with both traditional fiat and blockchain transaction rails that underpin our fast and affordable digital financial service offerings. Telcoin combines the best parts of the burgeoning DeFi ecosystem with our compliance-focused approach to each market, ensuring that the company takes on a fraction of traditional financial counterparty, execution, and custody risks.  The Telcoin Association is a Swiss non-profit organization domiciled in Lugano, Switzerland and is governed by a decentralized group of Miner Councils that run the various aspects of the Telcoin Platform, including the management of the Telcoin (TEL) token. Read more about the Telcoin Association [here](https://www.telcoin.org).

Telcoin

Telcoin ($TEL) is trending amidst high anticipation for the finalization and opening of its Digital Asset Bank in Nebraska, which received charter approval and is poised to launch eUSD, a regulated, bank-issued US dollar stablecoin. The community is actively discussing Telcoin's compliance-first approach and its potential to bridge traditional finance with decentralized finance, often drawing comparisons to early growth stages of other established cryptocurrencies. Many perceive Telcoin as a foundational player in regulated digital cash and a significant long-term opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know

AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.

<ul class="summary-bullets"><li>Fitch believes companies with portfolios focused on oncology, immunology, rare diseases, vaccines and metabolic or weight‑management therapies are likely to outgrow the market.&nbsp;</li><li>The firm deems policy risk, particularly regarding drug pricing, as high.&nbsp;</li><li>Fitch now expects global pharma revenue growth to be around 3.2% in 2026.&nbsp;</li></ul><p>Fitch Ratings said on Tuesday that it expects mid-single-digit growth in global medicines spending in 2026, supported by an aging population and broadening access to healthcare.</p><p>The global pharma sector’s operating environment will remain stable supporting a ‘neutral’ outlook, Fitch Ratings <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.fitchratings.com/research/corporate-finance/global-pharmas-2026-demand-growth-resilient-a-test-year-for-margins-23-12-2025">said</a>, while adding that companies with portfolios focused on oncology, immunology, rare diseases, vaccines and metabolic or weight‑management therapies are likely to outgrow the market.</p><h2 class="st-heading-2">Policy Risks</h2><p>Fitch, however, flagged risks including policy uncertainty testing operating profitability. Fitch deems policy risk, particularly regarding drug pricing, as high.</p><p>“In the US, the Most Favoured Nation pricing framework, potential import tariffs and evolving pharmacy benefit manager access dynamics are likely to increase pricing dispersion and cost volatility in 2026,” it said. “Issuers with diversified portfolios, domestic manufacturing options and inventory flexibility should preserve rating headroom despite policy volatility.”</p><p>Fitch now expects global pharma revenue growth to be around 3.2% in 2026, below the 5.3% expected in 2025. The base case for revenue growth is underpinned by innovation and volume increases in chronic and specialty categories, it said. Players with specialized therapeutic depth and broad modality exposure are better positioned to sustain above-market trajectories, Fitch added.</p><h2 class="st-heading-2">M&amp;A Activity In 2026</h2><p>The firm now sees merger and acquisition activity to remain elevated in 2026, extending the 2025 rebound in biotech dealmaking that outdid 2024 levels. It also expects a sustained rise in capital expenditure as companies regionalize manufacturing and invest in complex biologics and cell and gene platforms.</p><h2 class="st-heading-2">Trump’s Most Favored Pricing Deals</h2><p>Last week, U.S. President Trump<a href="https://stocktwits.com/news-articles/markets/equity/trump-strikes-new-drug-price-deals-with-roche-novartis-merck-and-other-pharma-giants/cLe0duBREtP"> announced</a> nine new agreements with pharma companies to lower prescription drug prices for Americans to levels paid in other developed nations. Overall, 14 pharma companies have now inked similar deals with the administration in return for pharma tariff reprieve and expedited drug application reviews including Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, Pfizer, Eli Lilly and Sanofi.</p><p>The S&amp;P Pharmaceuticals Select Industry Index has gained about 31% this year while the Dow Jones U.S. Pharmaceuticals Index gained over 24%.</p><p>Large-cap pharma stocks like Eli Lilly, Johnson &amp; Johnson, and Merck have all gained single to double digit stock growth this year while Pfizer fell 6%.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/pfizer-confirms-death-of-patient-enrolled-in-hemophilia-drug-study/cLepu4KREHO">Pfizer Confirms Death Of Patient Enrolled In Hemophilia Drug Study</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

Young female scientist working in laboratory (Representative image courtesy of Solskin via Getty Images)

Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk

The firm also expects merger and acquisition activity in the sector to remain elevated in 2026. 

Equity

GSK PLC Sponsored ADR (NYSE:GSK) Given Average Rating of "Hold" by Brokerages

Shares of GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) have been given a consensus recommendation of "Hold" by the eight research firms that are covering the stock, MarketBeat.com reports. Two...

Wendy Becker Acquires 441 Shares of GSK (LON:GSK) Stock

GSK plc (LON:GSK - Get Free Report) insider Wendy Becker purchased 441 shares of the business's stock in a transaction that occurred on Friday, December 19th. The shares were bought at an average...

GSK (LON:GSK) Insider Purchases 7,977.69 in Stock

GSK plc (LON:GSK - Get Free Report) insider Wendy Becker bought 441 shares of the stock in a transaction on Friday, December 19th. The stock was purchased at an average cost of GBX 1,809 per share...

Insider Buying: GSK (LON:GSK) Insider Purchases 1,650 Shares of Stock

GSK plc (LON:GSK - Get Free Report) insider Jonathan Symonds purchased 1,650 shares of the company's stock in a transaction dated Monday, December 22nd. The stock was purchased at an average cost of...

US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says

Roche CEO predicts higher drug costs in Switzerland due to U.S. government's deals with pharmaceutical companies.read more...

Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals

Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.

Samsung Biologics To Acquire GSK's Rockville Facility For US$280 Mln

(RTTNews) - Samsung Biologics (207940.KS) announced that its wholly owned U.S. subsidiary, Samsung Biologics America, will acquire 100% of Human Genome Sciences from GSK (GSK, GSK.L) for US$280...

Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK

Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK
Glaxosmithkline plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GSK News

GSKGlaxosmithkline plc - ADR